Results 71 to 80 of about 989 (143)

Supplementary Material for: Effect of Bilastine on Chronic Urticaria: A Systematic Review and Meta-Analysis

open access: yes, 2022
Background: Allergic diseases are a public health problem with the largest number of patients and the widest age distribution. Chronic urticaria (CU) is a common clinical allergic disease.
Li N. (3356369)   +8 more
core   +1 more source

A Comparative Study to Evaluate the Effects of Fluticasone Nasal Spray with Oral Bilastine Versus Mometasone Nasal Spray with Oral Bilastine in Patients of Moderate to Severe Rhinitis

open access: yes, 2023
Background: Rhinitis is defined as inflammation of the lining of the nose and is characterized by nasal symptoms including rhinorrhea, sneezing, nasal blockage and itching of the nose.
Mishra, Shiva
core  

Development and characterization of bilastine nanosuspension for enhanced dissolution in orodispersible films

open access: yesOpenNano
Bilastine, a second-generation antihistamine, is commonly prescribed for managing allergic rhinoconjunctivitis and urticaria due to its prolonged action.
Sarah Adnan Oudah, Eman B.H. Al-Khedairy
doaj   +1 more source

EFFICACY OF ORAL BILASTINE MONOTHERAPY VERSUS ORAL PROBIOTICS IN PATIENTS WITH ALLERGIC RHINITIS: AN OBSERVATIONAL COMPARATIVE STUDY 

open access: yesGlobal Journal of Public Health Medicine
   Introduction: Allergic rhinitis (AR) is among the most common chronic disorders encountered in otorhinolaryngology practice, and pharmacotherapy with second-generation oral antihistamines remains the mainstay of symptomatic treatment.
Shweta Sawant   +4 more
doaj   +1 more source

UV SPECTROPHOTOMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF BILASTINE USING EXPERIMENTAL DESIGN FOR ROBUSTNESS [PDF]

open access: yes
Bilastine is a novel nonsedative H1-receptor antagonist, which may be used for the symptomatic treatment of chronic idiopathic urticaria (CU). This study describes the validation of an UV spectrophotometric method for quantitative determination of ...
Rossi Brabo, Gabriela   +5 more
core   +1 more source

Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving

open access: yes, 2016
Introduction: Rational selection of a second-generation H-1-antihistamine requires efficacy and safety considerations, particularly regarding central nervous system (CNS) effects (cognitive and psychomotor function), potential for driving impairment ...
Jáuregui, I.   +6 more
core   +1 more source

Modern aspects of treatment of allergic rhinitis

open access: yesМедицинский совет, 2019
The importance of allergic diseases is due to their increasing prevalence in both developed and developing countries. The prevalence of allergic diseases in most countries of the world is 10–30% among urban and rural population. In the regions of Russia,
D. V. Shabanov, V. N. Fedoseeva
doaj   +1 more source

Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review

open access: yes, 2011
Background: The ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines development group examined the properties of oral H-1-antihistamines and made proposals about an 'optimal' drug.
Piotr Kuna   +44 more
core   +1 more source

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

open access: yesTherapeutics and Clinical Risk Management, 2016
Xue Yan Wang,1 Margaret Lim-Jurado,2 Narayanan Prepageran,3 Pongsakorn Tantilipikorn,4 De Yun Wang5 1Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2St Luke’s Medical Center,
Wang XY   +4 more
doaj  

Comparison of the Efficacy and Safety of Levocetirizine versus Bilastine for the Treatment of Chronic Spontaneous Urticaria in the Pediatric Population: An Observer-blinded Randomized Control Trial

open access: yesIndian Journal of Paediatric Dermatology
Background: Chronic spontaneous urticaria (CSU) refers to urticaria that has no specific cause or trigger, present on most days of the week for 6 weeks or more.
Debashree Sahoo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy